CBD-rich cannabis extract improved symptoms in most of 18 autism spectrum disorder patients

Of 15 patients who adhered to treatment, 14 showed improvement in at least one of eight symptom categories. Nine of 10 non-epileptic patients improved 30%+ in at least one category. The strongest improvements were in seizures, ADHD, sleep disorders, and communication/social interaction deficits. Nine of 10 patients on other medications were able to reduce or withdraw them while maintaining improvements.

Observational cohort of 18 autistic patients (10 non-epileptic, 5 epileptic, 3 discontinued) treated with compassionate-use standardized CBD-enriched cannabis extract (75:1 CBD:THC ratio) for 6-9 months, evaluating eight symptom categories.

Autism spectrum disorder has limited pharmacological treatment options, and many existing medications have significant side effects. This is among the first published reports of CBD-rich extract specifically for autism symptoms in non-epileptic patients.

The overlap between autism and epilepsy has led researchers to explore anticonvulsant treatments for autism. These early results suggesting CBD-rich extracts may help non-epileptic ASD patients hint at shared biological mechanisms that extend beyond seizure control.

Very small sample (18 patients). No control group or blinding. Observational design subject to placebo effect and reporting bias. Non-standardized outcome measures. Three patients discontinued due to adverse effects, representing 17% attrition.